Filing Details
- Accession Number:
- 0001104659-19-077302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-31 16:02:25
- Reporting Period:
- 2019-06-03
- Accepted Time:
- 2019-12-31 16:02:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Fortress Biotech Inc. | FBIO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1713932 | Robyn Hunter | C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2019-06-03 | 2,297 | $1.10 | 220,619 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Shares acquired as purchases made under the Company's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
- Does not include 21,437 shares automatically sold by the Company's plan administrator to cover taxes due upon vesting of certain shares.
- Of the 220,619 shares, 125,000 shares are restricted stock units.